Peginterferon alfa-2b

From WikiMD.org
Jump to navigation Jump to search
Peginterferon alfa-2b
TermPeginterferon alfa-2b
Short definitionpeginterferon alfa-2b - (pronounced) (Peg-IN-ter-FEER-on AL-fuh.
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


peginterferon alfa-2b - (pronounced) (Peg-IN-ter-FEER-on AL-fuh. . . ) A drug used under the brand name Sylatron to prevent a melanoma from coming back after it's removed by surgery and under the brand name PEG-Intron to treat chronic hepatitis C. It's also being studied to treat other types of cancer . Peginterferon alfa-2b is a form of interferon alfa (a substance normally made by cells in the immune system) that is made in the laboratory and combined with a substance called PEG, which allows the drug to stay in the body longer. It's a type of cytokine and a type of immunomodulating agent. Also called SCH 54031

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski